39170-04-2

Basic information

• Product Name: 1-[(2E)-4-piperidin-1-ylbut-2-en-1-yl]-1,2-dihydropyridine
• CAS NO: 39170-04-2
• Molecular Formula: C₁₄H₂₂N₂
• Molecular Weight: 218.3379
• Mol File: 39170-04-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 349.7°C at 760 mmHg
• Flash Point: 153.8°C
• Density: 0.984g/cm³
• Vapor Pressure: 4.61E-05mmHg at 25°C
• Refractive Index: 1.535
• CAS DataBase Reference: 1-[(2E)-4-piperidin-1-ylbut-2-en-1-yl]-1,2-dihydropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[(2E)-4-piperidin-1-ylbut-2-en-1-yl]-1,2-dihydropyridine(39170-04-2)
• EPA Substance Registry System: 1-[(2E)-4-piperidin-1-ylbut-2-en-1-yl]-1,2-dihydropyridine(39170-04-2)

Safety Data

• Hazardous Substances Data: 39170-04-2(Hazardous Substances Data)

Usage

Explanation

The compound's full name, which describes its structure and components.

Explanation

The molecular formula represents the number of carbon (C), hydrogen (H), and nitrogen (N) atoms in the compound.

Explanation

The mass of one mole of the compound, which is the sum of the atomic masses of all the atoms in the molecular formula.

Explanation

The compound's structure consists of two fused rings, one being a piperidine ring (a six-membered nitrogen-containing ring) and the other being a dihydropyridine ring (a six-membered ring with two double bonds and one hydrogen).

Explanation

The compound has a specific arrangement of the double bond in the but-2-en-1-yl group, which is in the (2E) configuration.

Explanation

The compound is derived from piperidine, a six-membered nitrogen-containing ring, which is a common structural motif in many pharmaceutical drugs.

Explanation

The compound is used in the field of medicinal chemistry, which involves the design, synthesis, and development of pharmaceutical drugs.

Explanation

The compound's structure suggests that it may have the ability to block calcium channels, which could be useful in treating conditions like hypertension and angina.

Explanation

More research is needed to fully understand the compound's properties, potential applications, and effectiveness as a pharmaceutical drug.

Molar Mass

232.36 g/mol

Structure

Contains a piperidine ring and a dihydropyridine ring

Double Bond Geometry

(2E)-4-piperidin-1-ylbut-2-en-1-yl

Derivative of Piperidine

Yes

Application

Medicinal Chemistry

Potential Biological Activity

Calcium channel blocker

Further Research

Required

Upstream product

• 110-86-1 pyridine 
• 821-06-7 (E)-1,4-dibromobutene 

Relevant articles and documents

Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications

Reversible inhibitors (e.g., pyridostigmine bromide, neostigmine bromide) of carbamate origin are used in the early treatment of Myasthenia gravis (MG) to block acetylcholinesterase (AChE) native function and conserve efficient amount of acetylcholine for